PropertyValue
?:abstract
  • The article focuses on small vaccine maker Novavax, which will receive 2 billion U S dollar from the U S government and a nonprofit organization to develop coronavirus vaccine in the U S It is one of just seven vaccine makers to win funding from Operation Warp Speed, the multiagency U S government effort aiming to manufacture quickly at least 300 million doses of COVID-19 vaccines Novavax is working to win the first approvals from regulators as it will have a huge market advantage
is ?:annotates of
?:creator
?:journal
  • Science
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • The Long Shot
?:type
?:who_covidence_id
  • #918740
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/1dl18mkg>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/1dl18mkg>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all